Cargando…
FoxO1 as a tissue-specific therapeutic target for type 2 diabetes
Forkhead box O (FoxO) proteins are transcription factors that mediate many aspects of physiology and thus have been targeted as therapeutics for several diseases including metabolic disorders such as type 2 diabetes mellitus (T2D). The role of FoxO1 in metabolism has been well studied, but recently...
Autores principales: | Teaney, Nicole A., Cyr, Nicole E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629996/ https://www.ncbi.nlm.nih.gov/pubmed/37941908 http://dx.doi.org/10.3389/fendo.2023.1286838 |
Ejemplares similares
-
FoxO1 breaks diabetic heart
por: Nagao, Mototsugu, et al.
Publicado: (2013) -
Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter
por: Tian, Yu-Nan, et al.
Publicado: (2020) -
Hepatic IGF2/H19 Epigenetic Alteration Induced Glucose Intolerance in Gestational Diabetes Mellitus Offspring via FoxO1 Mediation
por: Jiang, Ying, et al.
Publicado: (2022) -
FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice
por: Liu, Yun-zi, et al.
Publicado: (2019) -
Targeting FoxO1 with AS1842856 Suppresses Adipogenesis
por: Zou, Peng, et al.
Publicado: (2014)